# Patent blue V

## Patent blue V inj 50mg/2mL

| 藥物代碼           | IPAT                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Identification of lymph vessels and arterial territories.                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 副作用             | Hypotension, nausea, laryngeal edema, pruritus.                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 禁忌               | Hypersensitivity.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 藥物保存方式       | 室溫                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 用法用量           | Location of lymphatic vessels: approximately 1mL of Patent Blue V is injected into the subcutaneous tissue. Location of arterial territories: Intra-arterial injection of Patent Blue V results in a colouring of the tissues vascularised by the vesseis. To control the correct position of the catheter destined ti intra-arterial chimiotherapy, 50mL of a solution comprised of: *80mL of an isotonic sodium in water solution *40mL of a 2.5% Patent Blue V solution *20mL of a 1% xylocaine solution are perfused. |
| 肝功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 懷孕用藥危分級     | 儘量避免                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 孕期用藥建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 哺乳期用藥建議     | Unknown 尚未建立                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 注射劑給藥建議途徑 | IA, LI, SC                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 注意事項           | 1. 動脈注射Patent Blue V能將有血管的組織染色，一次灌注以下混合溶液的50mL溶液，溶液包含: *80mL等張鈉水溶液。 *40mL 2.5%Patent Blue V溶液。 *20mL 1%Xylocaine溶液。 2. Patent blue V 可能產生過敏副作用，注射前需了解病患過去有無過敏或不良反應記錄，必要時可事先投予Corticosteroid 與 Antihistamine。                                                                                                                                                                                                                      |

